SHP-1 acts as a tumor suppressor by directly interacting with EGFR in breast cancer growth and invas

来源 :第十四届全国肿瘤生物治疗大会 | 被引量 : 0次 | 上传用户:gaoliqiang
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background: Studies in other cancers have implicated SHP-1 in cell proliferation, anti-apoptotic activity and cell invasion.The present study was initiated to examine the role of SHP-1 in regulation of breast cancer cell growth and metastasis signaling and its expression in breast tissue samples.
其他文献
EB病毒目前已经证实与多种肿瘤发生密切相关,包括伯基特淋巴瘤、霍奇金淋巴瘤、鼻咽癌、胃癌以及淋巴细胞增生症。虽然EB病毒特异的CTL细胞在治疗EB病毒相关的淋巴细胞增生症中取得很好的疗效,但是由于EB病毒相关肿瘤下调EB病毒相关蛋白,从而使得EB病毒特异的CTL细胞治疗EB病毒相关肿瘤疗效欠佳。
Gemcitabine is a therapeutic agent for advanced breast cancer with high antitumor activity and relatively mild toxicity.Several clinical trials revealed that estrogen receptor (ER) status had relevanc
Tumor-induced, myeloid-derived suppressor cells (MDSCs)-mediated immune dysfunction is an important mechanism that leads to tumor immune escape and the inefficacy of cancer immunotherapy.Importantly,t
Toll-like receptor (TLR) 4-mediated signaling has been shown to be important to tumor cell survival,invasion and metastasis in a variety of cancers.The present study aimed to explore the role and down
Increased expression of galectin-1 (Gal-1) in carcinoma-associated fibroblasts (CAFs) has been reported to correlate with progression and prognosis in many cancers.However, rarely have reports sought
Metastasis is responsible for more than 90% of the mortality observed among patients with breast cancer.Human phosphatidylethanolamine-binding protein 4 (hPEBP4) is a novel member of the PEBP family a
Objective: The epidermal growth factor receptor pathway substrate 8 (EPS8) plays a critical role in the proliferation, progression and metastasis of solid as well as hematological cancers, and thus co
BACKGROUND:Non-Hodgkins Lymphoma is one of the highly invasion tumor in hematology, with the amazing growth rate and complex pathology characteristics.More than 50%-60% patients with aggressive B-cell
目的:研究肿瘤坏死因子α(TNF-α)诱导下,膀胱癌细胞中NF-κB通路分子的表达变化及其对细胞增殖水平的影响。方法:50 ng/ml TNF-α分别处理T24、5637膀胱癌细胞株,应用实时荧光定量PCR检测TNFα处理后膀胱癌T24、5637细胞株NF-κB信号通路中RelA、RelB基因表达的改变,CCK-8 (cell counting kit-8)法检测处理后细胞增殖活性的变化情况。
研究背景:急性髓系白血病是一种常见的恶性肿瘤增生性疾病,中位发病年龄为64~70岁,属于老年性疾病。现代的治疗是以联合化疗和造血干细胞移植为主,但大剂量联合化疗后严重的副作用和老年患者的无法耐受,且复发率高存在耐药现象;而造血干细胞移植也由于供体来源和经济条件的限制而无广泛应用,也有一定的复发机率。一般认为白血病的复发和耐药的根本原因是白血病体内存在白血病干细胞(leukemia stem cel